{"entity":{"type":"insider","cik":"0001409939","url":"/insider/0001409939","json_url":"/insider/0001409939.json","name":"GILL JOHN","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":5,"first":"2017-06-06","last":"2026-04-06","span_basis":"filed_date"},"name_variants":[{"name":"GILL JOHN","source":"filing","n_filings":5,"first_seen":"2017-06-06","last_seen":"2026-04-06"}],"transactions":[{"id":5946189,"accession":"0001409939-26-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001409939-26-000002","line_url":"/filing/0001409939-26-000002#line-1","is_derivative":false,"issuer_cik":"0001326190","issuer_name":"Altimmune, Inc.","issuer_ticker":"ALT","issuer_name_source":null,"issuer_url":"/issuer/0001326190","owner_cik":"0001409939","owner_name":"GILL JOHN","owner_display_name":"GILL JOHN","owner_url":"/insider/0001409939","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.0001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9200.0,"shares_display":"9,200","price_per_share":3.4076,"price_display":"3.41","price_state":"stated","total_value":31349.92,"total_display":"31,349.92","total_whole":"31,350","shares_owned_after":21700.0,"shares_owned_after_display":"21,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-06","filed_date":"2026-04-06","scope":"insider"},{"id":5152440,"accession":"0001409939-25-000005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001409939-25-000005","line_url":"/filing/0001409939-25-000005#line-1","is_derivative":false,"issuer_cik":"0001326190","issuer_name":"Altimmune, Inc.","issuer_ticker":"ALT","issuer_name_source":null,"issuer_url":"/issuer/0001326190","owner_cik":"0001409939","owner_name":"GILL JOHN","owner_display_name":"GILL JOHN","owner_url":"/insider/0001409939","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.0001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12500.0,"shares_display":"12,500","price_per_share":4.1,"price_display":"4.10","price_state":"stated","total_value":51250.0,"total_display":"51,250.00","total_whole":"51,250","shares_owned_after":12500.0,"shares_owned_after_display":"12,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-23","filed_date":"2025-12-23","scope":"insider"},{"id":8697521,"accession":"0001104659-23-078839","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-078839","line_url":"/filing/0001104659-23-078839#line-1","is_derivative":false,"issuer_cik":"0001326190","issuer_name":"Altimmune, Inc.","issuer_ticker":"ALT","issuer_name_source":null,"issuer_url":"/issuer/0001326190","owner_cik":"0001409939","owner_name":"GILL JOHN","owner_display_name":"GILL JOHN","owner_url":"/insider/0001409939","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.0001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2714.0,"shares_display":"2,714","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":40710.0,"total_display":"40,710.00","total_whole":"40,710","shares_owned_after":2771.0,"shares_owned_after_display":"2,771","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-12","filed_date":"2023-07-06","scope":"insider"},{"id":3240005,"accession":"0000899243-20-032575","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-032575","line_url":"/filing/0000899243-20-032575#line-1","is_derivative":false,"issuer_cik":"0001326190","issuer_name":"Altimmune, Inc.","issuer_ticker":"ALT","issuer_name_source":null,"issuer_url":"/issuer/0001326190","owner_cik":"0001409939","owner_name":"GILL JOHN","owner_display_name":"GILL JOHN","owner_url":"/insider/0001409939","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.0001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8425.0,"shares_display":"8,425","price_per_share":11.92,"price_display":"11.92","price_state":"stated","total_value":100426.0,"total_display":"100,426.00","total_whole":"100,426","shares_owned_after":11199.0,"shares_owned_after_display":"11,199","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-30","filed_date":"2020-12-02","scope":"insider"},{"id":4929187,"accession":"0001012975-17-000474","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-17-000474","line_url":"/filing/0001012975-17-000474#line-1","is_derivative":false,"issuer_cik":"0001326190","issuer_name":"Altimmune, Inc.","issuer_ticker":"ALT","issuer_name_source":null,"issuer_url":"/issuer/0001326190","owner_cik":"0001409939","owner_name":"GILL JOHN","owner_display_name":"GILL JOHN","owner_url":"/insider/0001409939","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.0001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":4.3435,"price_display":"4.34","price_state":"stated","total_value":4343.5,"total_display":"4,343.50","total_whole":"4,344","shares_owned_after":83224.0,"shares_owned_after_display":"83,224","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-02","filed_date":"2017-06-06","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":2,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001326190","name":"Altimmune, Inc.","url":"/issuer/0001326190","role":"Director","n_filings":5,"first_seen":"2017-06-06","last_seen":"2026-04-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001409939","retrieved_at":"2026-08-27T02:46:30+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}